Cambia means change.Cambia is an independent non-profit institute creating new technologies, tools and paradigms to promote change and enable innovation.
Transparency tools in gene patenting for informing policy and practice
Nature Biotechnology, December 06, 2013
The Supreme Court’s decision in Myriad highlights the need for tools enabling
nuanced and precise analysis of gene patents at the global level. The decision
underscores a pressing need for precise analysis of patents that disclose and
reference genetic sequences, especially in the claims. Similarly, data sets,
standards compliance and analytical tools must be improved— in particular, data
sets and analytical tools must be made openly accessible— in order to provide a
basis for effective decision making and policy setting to
- Skip to main menu
- Or continue reading for footer links and information.